Table 3 Age-specific and overall prevalences and 95% CIs for conditions of interest by age group and for all refugees with consults at MdM clinics across refugee camps on mainland Greece, 2016–2017

Asthma

45

1.23%

(0.87–1.59)

36

1.13%

(0.76–1.50)

19

2.2%

(1.2–3.1)

1

0.68%

(0.00–2.01)

101

1.28%

(1.04–1.53)

Hypertension

3

0.08%

(0.0 0- 0.18)

28

0.88%

(0.55–1.20)

94

10.64%

(8.61–12.68)

49

33.11%

(25.44–40.77)

174

2.21%

(1.89–2.54)

Hepatitis B

0

-

-

4

0.13%

(0.00–0.25)

0

-

-

1

0.68%

(0.00–2.01)

5

0.06%

(0.01–0.12)

Herpes

20

0.55%

(0.31–0.79)

22

0.69%

(0.40–0.98)

6

0.68%

(0.14–1.22)

0

-

-

48

0.61%

(0.44–0.78)

IDDM

2

0.05%

(0.00–0.13)

4

0.13%

(0.00–0.25)

9

1.02%

(0.36–1.68)

2

1.35%

(0.00–3.23)

17

0.22%

(0.11–0.32)

LRTI

247

6.76%

(5.95–7.57)

117

3.67%

(3.02–4.33)

53

6.00%

(4.43–7.57)

15

10.14%

(5.22–15.05)

432

5.49%

(4.99–6.00)

Musculoskeletal

92

2.52%

(2.01–3.03)

130

4.09%

(3.40–4.77)

48

5.44%

(3.93–6.93)

16

10.81%

(5.75–15.87)

286

3.64%

(3.22–4.05)

NIDDM

1

0.03%

(0.00–0.08)

11

0.35%

(0.14–0.55)

68

7.70%

(5.94–9.46)

19

12.84%

(7.39–18.29)

99

1.26%

(1.01–1.50)

Tonsilitis

489

13.39%

(12.28–14.49)

349

10.97%

(9.88–12.05)

73

8.27%

(6.45–10.09)

11

7.43%

(3.15–11.71)

922

11.72%

(11.01–12.43)

Tuberculosis

18

0.49%

(0.27–0.72)

10

0.31%

(0.12–0.51)

8

0.91%

(0.28–1.53)

2

1.35%

(0.00–3.23)

38

0.48%

(0.33–0.64)

URTI

1681

46.03%

(44.41–47.65)

940

29.54%

(27.96–31.13)

224

25.37%

(22.49–28.24)

45

30.41%

(22.91–37.90)

2890

36.75%

(35.67–37.81)